Brinker Capital Investments’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.14M | Sell |
3,866
-56
| -1% | -$15.9K | 0.01% | 1088 |
|
|
2026
Q1 | $1.09M | Sell |
3,922
-285
| -7% | -$82.1K | 0.01% | 1069 |
|
|
2025
Q4 | $1.27M | Sell |
4,207
-205
| -5% | -$64K | 0.01% | 1104 |
|
|
2025
Q3 | $1.24M | Buy |
4,412
+1,219
| +38% | +$332K | 0.01% | 1113 |
|
|
2025
Q2 | $771K | Sell |
3,193
-217
| -6% | -$51.3K | 0.01% | 1329 |
|
|
2025
Q1 | $831K | Buy |
3,410
+146
| +4% | +$43.9K | 0.01% | 1178 |
|
|
2024
Q4 | $1.07M | Sell |
3,264
-219
| -6% | -$74.3K | 0.01% | 1013 |
|
|
2024
Q3 | $1.17M | Sell |
3,483
-201
| -5% | -$63.8K | 0.01% | 964 |
|
|
2024
Q2 | $1.01M | Sell |
3,684
-367
| -9% | -$107K | 0.01% | 988 |
|
|
2024
Q1 | $1.4M | Sell |
4,051
-2,048
| -34% | -$673K | 0.02% | 833 |
|
|
2023
Q4 | $1.96M | Sell |
6,099
-2,012
| -25% | -$631K | 0.02% | 642 |
|
|
2023
Q3 | $2.91M | Sell |
8,111
-340
| -4% | -$131K | 0.04% | 457 |
|
|
2023
Q2 | $3.2M | Buy |
8,451
+604
| +8% | +$246K | 0.03% | 457 |
|
|
2023
Q1 | $3.76M | Sell |
7,847
-206
| -3% | -$96.4K | 0.05% | 341 |
|
|
2022
Q4 | $3.39M | Buy |
8,053
+1,387
| +21% | +$560K | 0.07% | 290 |
|
|
2022
Q3 | $2.78M | Buy |
6,666
+681
| +11% | +$340K | 0.06% | 332 |
|
|
2022
Q2 | $2.96M | Sell |
5,985
-184
| -3% | -$95.8K | 0.06% | 324 |
|
|
2022
Q1 | $3.48M | Sell |
6,169
-2,835
| -31% | -$1.71M | 0.05% | 340 |
|
|
2021
Q4 | $6.8M | Sell |
9,004
-2,148
| -19% | -$1.61M | 0.1% | 200 |
|
|
2021
Q3 | $7.23M | Buy |
11,152
+3
| +0% | +$2.25K | 0.11% | 183 |
|
|
2021
Q2 | $7.18M | Buy |
11,149
+5,168
| +86% | +$3.15M | 0.1% | 225 |
|
|
2021
Q1 | $3.42M | Sell |
5,981
-12,266
| -67% | -$7.26M | 0.05% | 345 |
|
|
2020
Q4 | $10.6M | Buy |
18,247
+10,280
| +129% | +$5.85M | 0.16% | 137 |
|
|
2020
Q3 | $4.11M | Buy |
7,967
+7,518
| +1,674% | +$3.81M | 0.07% | 282 |
|
|
2020
Q2 | $203K | Buy |
+449
| New | +$198K | 0.01% | 305 |
|
|
2020
Q1 | – | Sell |
-448
| Closed | -$166K | – | 349 |
|
|
2019
Q4 | $166K | Hold |
448
| – | – | 0.01% | 334 |
|
|
2019
Q3 | $149K | Hold |
448
| – | – | 0.01% | 345 |
|
|
2019
Q2 | $140K | Hold |
448
| – | – | ﹤0.01% | 434 |
|
|
2019
Q1 | $137K | Sell |
448
-52
| -10% | -$14K | ﹤0.01% | 370 |
|
|
2018
Q4 | $116K | Hold |
500
| – | – | ﹤0.01% | 341 |
|
|
2018
Q3 | $156K | Hold |
500
| – | – | ﹤0.01% | 305 |
|
|
2018
Q2 | $144K | Hold |
500
| – | – | ﹤0.01% | 316 |
|
|
2018
Q1 | $125K | Buy |
+500
| New | +$127K | ﹤0.01% | 305 |
|
Other funds holding BIO
AI
Brinker Capital Investments's BIO Position: Q2 2026 in Review
Brinker Capital Investments reduced its Bio-Rad Laboratories Class A (BIO) stake by 1.4% in Q2 2026, selling an estimated $15.9K and leaving 3,866 shares worth $1.14M. The position accounts for 0.01% of the portfolio, ranked #1088.
Brinker Capital Investments first reported a position in BIO in Q1 2018 and has held it in 33 quarters since. The position peaked at $10.6M in Q4 2020. 400 funds tracked by Wall St. Rank hold BIO as of Q2 2026.
- Brinker Capital Investments held 3,866 shares of Bio-Rad Laboratories Class A worth $1.14M as of Q2 2026.
- Brinker Capital Investments sold 56 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $15.9K.
- Bio-Rad Laboratories Class A made up 0.01% of Brinker Capital Investments's portfolio in Q2 2026, its #1088 holding.
- Brinker Capital Investments first reported a position in Bio-Rad Laboratories Class A in Q1 2018 and has held it in 33 quarters since.
- Brinker Capital Investments's Bio-Rad Laboratories Class A position peaked at $10.6M in Q4 2020.
- 400 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.
Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.